Sharon Bracken
Head of Diagnostics, Siemens Healthineers
Sharon Bracken has served as Head of Diagnostics since May 2022. She currently oversees Siemens Healthineers’ in-vitro diagnostics businesses, which provide industry-leading technology, assays, and software for central lab and point of care testing environments. The test menu Siemens Healthineers provides supports patient testing needs from conception through all stages of life. Sharon has 20 years of in-vitro diagnostics experience and more than 30 years of global business leadership experience.
Areas of expertise: Trends in IVD testing, macro-view diagnostics testing topics (innovation, longevity, exploration of AI in testing), point-of-care testing trends, laboratory workforce shortage, Diagnostics business strategy.
To schedule an interview please contact:
Kimberly Nissen
Senior Public Relations Manager
+1 (610) 448-6355
Kimberly.nissen@siemens-healthineers.com
Vibhas Deshpande
Vice President, Sustainability Innovation and Strategic Research, North America
Vibhas Deshpande leads development of innovations in sustainability to reduce the environmental impact of healthcare. He is also responsible for identifying strategic research areas for Siemens Healthineers in disease-focused diagnostics and therapeutic pathways. Among Vibhas’ achievements is conceptualizing and initiating the first carbon-neutral radiology imaging service between Siemens Healthineers and the University of California San Francisco.
Areas of expertise: Reducing carbon emissions in the lifecycle of medical imaging equipment and curbing greenhouse gas emission and energy consumption in healthcare operations.
To schedule an interview please contact:
Jeffrey T. Bell
Senior Public Relations Manager
+1 (484) 868-8346
Jeffrey.t.bell@siemens-healthineers.com
Felicia Kurz
SVP, Head of Advanced Therapies North America | Executive Sponsor, Health Equity and Outreach
Felicia’s responsibilities include oversight of the Interventional Therapies business (Cardiology, Interventional Radiology, and Neuroradiology) as well as Surgical Therapies, encompassing all forms of surgical image guidance. Felicia is also the executive sponsor for the company’s health equity and outreach activities in the U.S.
Areas of expertise: Felicia has a background in health economics, international health policy and analysis. She specializes in clinical care pathways (e.g., cardiovascular and neurovascular care) and transforming strategy into action to support health systems in achieving their clinical, operational, and financial goals. She also drives collaborative efforts of Siemens Healthineers and U.S. customers to expand patient access to care, particularly in underserved communities (e.g., free annual digital mammogram screenings).
To schedule an interview please contact:
Jeffrey T. Bell
Senior Public Relations Manager
+1 (484) 868-8346
Jeffrey.t.bell@siemens-healthineers.com
François Nolte
Global Lead, Networked Care
François collaborates with a diverse team of Healthineers to enable and expand healthcare delivery across existing and new networks of care. As governments, providers and health systems strive to make high quality healthcare affordable, more and more decentralized care locations are being deployed. Francois and his team think deeply about how to create smartly connected distributed systems of care and how these systems could make healthcare better for everyone.
Areas of expertise: Making healthcare safer outside of big hospitals, including factors driving the growing trend of offsite patient care at ambulatory surgery centers (ASCs) and office-based labs (OBLs), the types of patient procedures performed in these offsite facilities and the benefits of this emerging approach for patients and healthcare providers.
To schedule an interview please contact:
Kimberly Nissen
Senior Public Relations Manager
+1 (610) 448-6355
Kimberly.nissen@siemens-healthineers.com
Dave Pacitti
President and Head of the Americas, Siemens Healthineers
Dave is responsible for leading the marketing, sales, service, and support functions in North America and Latin America, across medical imaging, laboratory diagnostics, therapy solutions and services. He serves on the boards of Apollo Endo-Surgery, the Advanced Medical Technology Association (AdvaMed), the University City Science Center in Philadelphia, the National Electrical Manufacturers Association (NEMA) and the Siemens Foundation.
Areas of expertise: trends in medical technology; value partnerships, which are long-term arrangements between Siemens Healthineers and hospital systems designed to ensure access to the latest and best medical technology and expand access to care for underserved populations and regions.
To schedule an interview please contact:
Julie Gibson
Head of U.S. Corporate Press
+1 (917) 929-5779
Julie.gibson@siemens-healthineers.com
Rangarajan (Ranga) Sampath, PhD
Head of Center for Innovation in Diagnostics, Siemens Healthineers
Ranga leads innovation and new product development in the areas of infectious diseases, neurology, and oncology for the company’s Diagnostics business. CID’s focus is to drive disruptive next-generation innovation, and development and commercialization of in-vitro diagnostics, automation, and digital health solutions.
Areas of expertise: innovation trends in diagnostics, sepsis, neurology, biomarkers, digital health, clinical decisioning, climate change impact on health, pandemic preparedness, infectious diseases.
To schedule an interview please contact:
Kimberly Nissen
Senior Public Relations Manager
+1 (610) 448-6355
Kimberly.nissen@siemens-healthineers.com
Peter Shen
Head of North American Digital & Automation
In his more than two decades in healthcare, Peter has specifically focused on introducing new and emerging technologies to the healthcare market, including artificial intelligence, imaging IT, 3D advanced visualization, data analytics and digital ecosystems. He is an industry leader in healthcare imaging IT, serving on national standardization committees, engaging with major health providers, and routinely speaking with leading technology partners.
Areas of expertise: How AI is being integrated into nearly every aspect of patient care, from exams to diagnosis to treatment, to help clinicians achieve a more accurate diagnosis faster and develop a personalized patient treatment plan. Also, emerging trends in AI adoption in healthcare and existing barriers to more widespread implementation of AI in radiology and laboratory diagnostics.
To schedule an interview please contact:
Jeffrey T. Bell
Senior Public Relations Manager
+1 (484) 868-8346
Jeffrey.t.bell@siemens-healthineers.com
Donald Chalfin, MD, MS, MPH, FCCP, FCCM
Director, External Engagements and Collaborations for Diagnostics, Siemens-Healthineers
Dr. Donald Chalfin (“Dr. Don”) is a board-certified critical care and internal medicine physician, who has been with Siemens Healthineers since 2020, and has served on the Medical Affairs team for Diagnostics since 2022. Dr. Don is currently a medical director on the Medical Affairs team and has devoted many of his efforts to liver disease diagnostics, with a focus specifically on the Enhanced Liver Fibrosis ELF™ Test for advanced liver fibrosis. Among Dr. Don’s accomplishments are developing the Investigator Initiated Study Program for MASLD, MASH, and liver fibrosis diagnostics and contributing to the strategy for advanced liver fibrosis/ELF related studies, in pursuit of earlier detection of this silent killer. Dr. Don contributes his unique perspective as a patient affected by this disease. He is a part of the Sepsis Strategy Team for the Center for Innovation in Diagnostics at Siemens Healthineers and works with the health economics group on various studies. Dr. Don is a thought leader in critical care medicine and health economic methods and is passionate about graduate and undergraduate medical teaching. He has been an invited speaker at many national and international medical and scientific meetings along with his work on sepsis, other topics in critical care medicine, health economics, and more recently on his experience as a MASLD/MASH patient and liver transplant and liver cancer survivor. He continues to practice and see patients who require critical care services and ICU admission.
Areas of expertise:
NASH/MASH, NALFD/MAFLD, advanced liver fibrosis, sepsis and infectious diseases, in vitro and companion diagnostics, emerging technologies and therapeutic initiatives, critical care medicine, clinical trials, health economics and outcomes research
To schedule an interview please contact:
Kimberly Nissen
Senior Manager, Public Relations
+1 (610) 448-6355
kimberly.nissen@siemens-healthineers.com
